COMMUNIQUÉS West-GlobeNewswire

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
14/05/2024
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital [...]
CAROLINA MEADOWS NAMED ON U.S. NEWS & WORLD REPORT’S BEST INDEPENDENT LIVING AND BEST ASSISTED LIVING LISTS
14/05/2024
Chapel Hill, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- Carolina Meadows, one of the Southeast’s leading continuing care retirement communities, located in Chapel Hill, North Carolina, announced today its inclusion on U.S. [...]
Ballad Health and Sevaro Health Partner To Revolutionize Stroke Care, Just In Time for Stroke Awareness Month
14/05/2024
EAST BRUNSWICK, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- May is Stroke Awareness Month, and starting this May patients in the Appalachian Highlands region of Northeast Tennessee and Southwest Virginia will be able to [...]
Bon Natural Life Limited Announces Brand Strategic Cooperation with Guangdong JUWO
14/05/2024
XI’AN, China, May 14, 2024 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, [...]
Invitation to Idorsia's Full Year 2023 and Q1 2024 Financial Reporting webcast and conference call
14/05/2024
Idorsia will publish its Full Year 2023 and Q1 2024 Financial Reporting on Tuesday May 21, 2024, at 07:00 CEST. An investor conference call and webcast will be held to discuss the results on the same day. Date: Tuesday [...]
Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)
14/05/2024
Renowned gastrointestinal diseases conference to held in Washington, D.C. May 18-21, 2024 SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused [...]
Progyny, Inc. to Present at BofA Securities 2024 Healthcare Conference and Leerink Partners Healthcare Crossroads Conference 2024
14/05/2024
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Progyny’s executives will participate in a [...]
En pleine transformation stratégique, le King Faisal Specialist Hospital and Research Centre accueille un nouveau directeur général adjoint
14/05/2024
RIYAD, Arabie saoudite, 14 mai 2024 (GLOBE NEWSWIRE) -- L’hôpital spécialisé et centre de recherche King Faisal, ou KFSH&RC pour King Faisal Specialist Hospital and Research Centre a récemment accueilli le Dr Björn [...]
Notification of managers’ transactions
14/05/2024
ANNOUNCEMENT NO. 265 Notification of managers’ transactions ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S [...]
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
14/05/2024
Additional analyses of data from AURORA, as well as the full adult data set from BEACON Updated data from the ongoing Phase 1b study of DISC-0974 in myelofibrosis (MF) patients with anemia, including a larger data set [...]
Affimed Announces Acceptance of an Abstract on Preclinical Data of its Innate Cell Engager AFM28 at the European Hematology Association 2024 Congress
14/05/2024
Treatment with AFM28 innate cell engager (ICE®), designed to target CD123-positive cancer cells in patients with acute myeloid leukemia (AML), led to dose-dependent tumor growth control in a validated in vivo mouse [...]
Notification of managers’ transactions
14/05/2024
ANNOUNCEMENT NO. 264 Notification of managers’ transactions ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S [...]
Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress
14/05/2024
Media Release COPENHAGEN, Denmark; May 14, 2024 Sixteen abstracts accepted for presentation and publication demonstrate depth and breadth of comprehensive epcoritamab development program Three oral presentations [...]
Kymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting
14/05/2024
Abstract released today highlights safety, pharmacodynamic and clinical response data collected through February 6, 2024 cut-off date Updated data to be presented at the European Hematology Association (EHA) Annual [...]
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
14/05/2024
– Data from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia to be Presented in Plenary Session – – Additional Presentations to Highlight Quality of Life Data from ENERGIZE and Design of the [...]
Nurix Therapeutics Announces Upcoming Oral Presentation of New Data from Ongoing Clinical Trial of NX-5948, a Selective Bruton’s Tyrosine Kinase (BTK) Degrader, at the European Hematology Association Congress (EHA2024)
14/05/2024
Overall response rate of 70% observed in 10 evaluable heavily pretreated CLL patients Data showcase deepening clinical responses with longer time on therapy in CLL patients including patients with resistance mutations [...]
Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June
14/05/2024
CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that two abstracts, including one oral presentation and one poster [...]
Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association
14/05/2024
LEXINGTON, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a [...]
IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
14/05/2024
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, announced today a presentation at the European [...]

Pages